Artelo Biosciences announces 3-for-1 reverse stock split

1 week ago 9

TipRanks

Sat, March 7, 2026 astatine 7:13 AM CST 1 min read

Artelo Biosciences (ARTL) announced that connected February 27, 2026, Artelo’s Board of Directors approved a 3-for-1 reverse banal divided of the Company’s communal stock. The Company’s communal shares volition statesman trading connected a split-adjusted ground connected the Nasdaq Capital Market commencing astatine the marketplace open, March 10, 2026. The Board of Directors determined the 3-for-1 ratio to beryllium due successful bid to summation the terms per stock of the Common Stock to amended its marketability and liquidity.

Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions
Stay up of the marketplace with the latest quality and investigation and maximize your portfolio's potential

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See today’s best-performing stocks connected TipRanks >>

Read More connected ARTL:

Disclaimer & DisclosureReport an Issue

Artelo Biosciences reports FY25 EPS ($12.52)
Artelo Biosciences Secures Flexible Multiyear Equity Financing
Artelo Biosciences Granted Nasdaq Extension to Regain Compliance
Artelo Biosciences Shareholders Back Board, Pay and Auditor
Artelo Biosciences faces caller Nasdaq compliance challenges

Read Entire Article